Research Article

Comparison of Rheological, Drug Release, and Mucoadhesive Characteristics upon Storage between Hydrogels with Unmodified or Beta-Glycerophosphate-Crosslinked Chitosan

Table 3

Changes in organoleptic properties, clotrimazole content, and drug particle size in hydrogels with unmodified CS (F1, F2) or with bGP-crosslinked CS (F3, F4) upon storage compared to values obtained to freshly prepared formulations.

Storage time (months)ParameterHydrogel with
Unmodified CSbGP-crosslinked CS
F1F2F3F4

0pH4.06 ± 0.024.08 ± 0.014.54 ± 0.044.56 ± 0.03
Particle size range (μm)6.0–49.56.0–47.04.0–40.04.0–41.5
Drug content (%)95.6 ± 4.998.2 ± 3.597.3 ± 4.197.4 ± 3.3

25°C/60% RH
1pH4.16 ± 0.054.23 ± 0.054.51 ± 0.044.53 ± 0.02
Particle size range (μm)7.5–52.57.5–57.06.0–29.55.0–48.5
Drug content (%)94.8 ± 3.396.1 ± 4.296.5 ± 3.597.1 ± 3.9
3pH4.40 ± 0.024.38 ± 0.034.35 ± 0.024.27 ± 0.03
Particle size range (μm)7.0–58.06.0–54.54.0–41.04.0–34.5
Drug content (%)94.6 ± 5.992.4 ± 5.198.1 ± 4.195.2 ± 4.5
6pH4.31 ± 0.024.39 ± 0.014.26 ± 0.024.23 ± 0.02
Particle size range (μm)n.d.n.d.SedimentationSedimentation
Drug content (%)n.d.n.d.n.d.n.d.

40°C/75% RH
1pH4.20 ± 0.034.24 ± 0.054.56 ± 0.044.51 ± 0.02
Particle size diameter (μm)SedimentationSedimentation10.0–53.05.0–61.0
Drug content (%)n.d.n.d.96.5 ± 3.597.1 ± 3.9
3pH4.40 ± 0.024.48 ± 0.024.36 ± 0.014.29 ± 0.03
Particle size range (μm)n.d.n.d.5.0–44.54.5–37.0
Drug content (%)n.d.n.d.93.1 ± 7.194.2 ± 6.8

4 ± 2°C
1pH4.10 ± 0.054.03 ± 0.054.56 ± 0.044.53 ± 0.02
Particle size range (μm)12.0–58.57.5–65.08.0–59.010.5–45.0
Drug content (%)94.3 ± 3.896.1 ± 4.296.5 ± 3.597.1 ± 3.9
3pH4.10 ± 0.024.12 ± 0.024.31 ± 0.024.37 ± 0.03
Particle size range (μm)Sedimentation6.0–59.511.0–40.05.0–45.5
Drug content (%)n.d.95.1 ± 8.498.1 ± 4.795.2 ± 4.5
6pH4.23 ± 0.034.29 ± 0.034.28 ± 0.034.37 ± 0.01
Particle size range (μm)n.d.n.d.6.5–46.05.0–40.0
Drug content (%)n.d.n.d.94.1 ± 4.996.0 ± 3.7

, mean ± SD; n.d.: not determined.